Autoimmune Disorder
5
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
14 treatments under study, led by Branebrutinib
Research Leaders
9 sponsors active, led by Johns Hopkins University
Related Conditions
Often studied with 10 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (5)
Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting
A Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy Participants
Modelling and Control of Non-invasive Vagus Nerve Stimulation for Autoimmune Diseases (1A)
Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
Research Network
Common Treatments
- Branebrutinib1
- Fatigue Severity Scale1
- Berg Balance Test1
- Parasym 30hz1
- Parasym 1hz1
Active Sponsors
- Johns Hopkins University1
- University of Pittsburgh1
- Hospital Mutua de Terrassa1
- Muğla Sıtkı Koçman University1
- Imperial College London1
Top Investigators
University of Pittsburgh
Related Conditions
- Systemic Lupus Erythematosus2
- Healthy Volunteers1
- Primary Sjögrens Syndrome1
- Vagus Nerve Autonomic Disorder1
- Rheumatoid Arthritis1